Mayne Pharma Group Limited (MAYNF)
OTCMKTS · Delayed Price · Currency is USD
3.515
0.00 (0.00%)
At close: Jul 21, 2025
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of $279.74 million as of July 25, 2025. Its market cap has increased by 19.39% in one year.
Market Cap
279.74M
Enterprise Value
223.96M
Revenue
255.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.52
Market Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 38.76M to 279.74M, an increase of 621.77%. That is a compound annual growth rate of 11.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 279.74M | 11.94% |
| Dec 31, 2024 | 249.89M | -26.63% |
| Dec 29, 2023 | 340.60M | 44.02% |
| Dec 30, 2022 | 236.50M | -37.53% |
| Dec 31, 2021 | 378.56M | -15.29% |
| Dec 31, 2020 | 446.91M | -12.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 781.22M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 588.92M |
| Glass House Brands | 416.79M |
| Northwest Biotherapeutics | 377.15M |
| CytoDyn | 376.49M |